Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

4 Résultats
authFullName_s : Reda Garidi

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

Caroline Houillier , Luc Taillandier , Sylvain Dureau , Thierry Lamy , Mouna Laadhari , et al.
Journal of Clinical Oncology, 2019, 37 (10), pp.823+. ⟨10.1200/JCO.18.00306⟩
Article dans une revue hal-03599523v1

Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial

Philippe Moreau , Cyrille Hulin , Aurore Perrot , Bertrand Arnulf , Karim Belhadj , et al.
Lancet Oncology, 2021, 22 (10), pp.1378-1390. ⟨10.1016/S1470-2045(21)00428-9⟩
Article dans une revue hal-03604926v1

Shared clonal IGH rearrangement in BCP-ALL occurring after CLL: pitfalls and implications for MRD monitoring

Coralie Derrieux , Alexandr Gish , Alexis Caulier , Nathalie Grardel , Reda Garidi , et al.
British Journal of Haematology, 2020, 191 (3), pp.506-509. ⟨10.1111/bjh.17008⟩
Article dans une revue hal-03604940v1

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau , Michel Attal , Cyrille Hulin , Bertrand Arnulf , Karim Belhadj , et al.
The Lancet, 2019, 394 (10192), pp.29-38. ⟨10.1016/S0140-6736(19)31240-1⟩
Article dans une revue hal-03605015v1